Close Menu

SGI

Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.

The synthetic biology and DNA data storage firm will use the funds to launch its BioXp 3200 automated gene synthesis and cloning platform.

The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.

Mycoplasma mycoides

A new study in Scientific Reports describes how scientists were able to replace an entire gene in a bacterial genome to study its function.

The deal covers SGI-DNA's line of DNA construct assembly kits, which are based on its Gibson Assembly DNA cloning approach, in North America and Europe.

SGI said this week that the Translational Research Institute, an Australian medical research and biopharmaceutical facility, has selected one of SGI's high-performance computing solutions to support its biomedical research efforts.

Japan's National Institute of Genetics has selected one of SGI's supercomputing systems to meet its next-generation sequence data analysis needs.

French biotech firm Biogemma has deployed an informatics infrastructure based on GenomeQuest's analysis workflows and SGI's Altix UV 1000 platform.

The firms have partnered on developing high-performance computing solutions for agriculture genomics.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.